Literature DB >> 18379424

Chocolate consumption in pregnancy and reduced likelihood of preeclampsia.

Elizabeth W Triche1, Laura M Grosso, Kathleen Belanger, Amy S Darefsky, Neal L Benowitz, Michael B Bracken.   

Abstract

BACKGROUND: Preeclampsia is a major pregnancy complication with cardiovascular manifestations. Recent studies suggest that chocolate consumption may benefit cardiovascular health.
METHODS: We studied the association of chocolate consumption with risk of preeclampsia in a prospective cohort study of 2291 pregnant women who delivered a singleton livebirth between September 1996 and January 2000. Chocolate consumption was measured by self report in the first and third trimesters, and by umbilical cord serum concentrations of theobromine, the major methylxanthine component of chocolate. Preeclampsia was assessed by detailed medical record review for 1943 of the women. We derived adjusted odds ratios (aOR) and 95% confidence intervals (CIs) from logistic regression models controlling for potential confounders.
RESULTS: Preeclampsia developed in 3.7% (n = 63) of 1681 women. Cord serum theobromine concentrations were negatively associated with preeclampsia (aOR = 0.31; CI = 0.11-0.87 for highest compared with lowest quartile). Self-reported chocolate consumption estimates also were inversely associated with preeclampsia. Compared with women consuming under 1 serving of chocolate weekly, women consuming 5+ servings per week had decreased risk: aOR = 0.81 with consumption in the first 3 months of pregnancy (CI = 0.37-1.79) and 0.60 in the last 3 months (0.30-1.24).
CONCLUSIONS: Our results suggest that chocolate consumption during pregnancy may lower risk of preeclampsia. However, reverse causality may also contribute to these findings.

Entities:  

Mesh:

Year:  2008        PMID: 18379424      PMCID: PMC2782959          DOI: 10.1097/EDE.0b013e31816a1d17

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  26 in total

1.  Association of maternal caffeine consumption with decrements in fetal growth.

Authors:  Michael B Bracken; Elizabeth W Triche; Kathleen Belanger; Karen Hellenbrand; Brian P Leaderer
Journal:  Am J Epidemiol       Date:  2003-03-01       Impact factor: 4.897

2.  Effects of theobromine should be considered in future studies.

Authors:  Caleb J Kelly
Journal:  Am J Clin Nutr       Date:  2005-08       Impact factor: 7.045

Review 3.  Caffeine metabolism, genetics, and perinatal outcomes: a review of exposure assessment considerations during pregnancy.

Authors:  Laura M Grosso; Michael B Bracken
Journal:  Ann Epidemiol       Date:  2005-07       Impact factor: 3.797

Review 4.  Potassium, magnesium, and electrolyte imbalance and complications in disease management.

Authors:  William Weglicki; Gary Quamme; Katherine Tucker; Mark Haigney; Larry Resnick
Journal:  Clin Exp Hypertens       Date:  2005-01       Impact factor: 1.749

5.  Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study.

Authors:  Brenda J Wilson; M Stuart Watson; Gordon J Prescott; Sarah Sunderland; Doris M Campbell; Philip Hannaford; W Cairns S Smith
Journal:  BMJ       Date:  2003-04-19

Review 6.  Methylxanthines: toxicity to humans. 3. Theobromine, paraxanthine and the combined effects of methylxanthines.

Authors:  B Stavric
Journal:  Food Chem Toxicol       Date:  1988-08       Impact factor: 6.023

7.  Cocoa reduces blood pressure and insulin resistance and improves endothelium-dependent vasodilation in hypertensives.

Authors:  Davide Grassi; Stefano Necozione; Cristina Lippi; Giuseppe Croce; Letizia Valeri; Paolo Pasqualetti; Giovambattista Desideri; Jeffrey B Blumberg; Claudio Ferri
Journal:  Hypertension       Date:  2005-07-18       Impact factor: 10.190

Review 8.  Preeclampsia: recent insights.

Authors:  James M Roberts; Hilary S Gammill
Journal:  Hypertension       Date:  2005-10-17       Impact factor: 10.190

9.  Flavanol-rich cocoa induces nitric-oxide-dependent vasodilation in healthy humans.

Authors:  Naomi D L Fisher; Meghan Hughes; Marie Gerhard-Herman; Norman K Hollenberg
Journal:  J Hypertens       Date:  2003-12       Impact factor: 4.844

10.  Xanthine oxidase/dehydrogenase is present in human placenta.

Authors:  A Many; A Westerhausen-Larson; A Kanbour-Shakir; J M Roberts
Journal:  Placenta       Date:  1996 Jul-Aug       Impact factor: 3.481

View more
  5 in total

1.  Does chocolate intake during pregnancy reduce the risks of preeclampsia and gestational hypertension?

Authors:  Audrey F Saftlas; Elizabeth W Triche; Hind Beydoun; Michael B Bracken
Journal:  Ann Epidemiol       Date:  2010-08       Impact factor: 3.797

2.  Maternal ingestion of cocoa causes constriction of fetal ductus arteriosus in rats.

Authors:  Paulo Zielinsky; Felipe Villa Martignoni; Melissa Markoski; Kelly Pozzer Zucatti; Gabriela Dos Santos Marinho; Gabriela Pozzobon; Pedro Rafael Magno; Victória de Bittencourt Antunes; Natassia Miranda Sulis; Alexandra Cardoso; Daniel Mattos; Alexandre Antônio Naujorks; Anize Delfino von Frankenberg; Izabele Vian
Journal:  Sci Rep       Date:  2021-05-11       Impact factor: 4.379

3.  Blood pressure and endothelial function in healthy, pregnant women after acute and daily consumption of flavanol-rich chocolate: a pilot, randomized controlled trial.

Authors:  Jaime Andres Mogollon; Emmanuel Bujold; Simone Lemieux; Mélodie Bourdages; Claudine Blanchet; Laurent Bazinet; Charles Couillard; Martin Noël; Sylvie Dodin
Journal:  Nutr J       Date:  2013-04-08       Impact factor: 3.271

4.  Consumption of chocolate in pregnant women and risk of preeclampsia: a systematic review.

Authors:  Jaime Andres Mogollon; Catherine Boivin; Kadhel Philippe; Stéphane Turcotte; Simone Lemieux; Claudine Blanchet; Emmanuel Bujold; Sylvie Dodin
Journal:  Syst Rev       Date:  2013-12-20

Review 5.  The association between dietary factors and gestational hypertension and pre-eclampsia: a systematic review and meta-analysis of observational studies.

Authors:  Danielle A J M Schoenaker; Sabita S Soedamah-Muthu; Gita D Mishra
Journal:  BMC Med       Date:  2014-09-22       Impact factor: 8.775

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.